Anticholinergic agent
ATROS-Z
Injection — 0.6 mg/ml
WHO-GMP
Product Overview
Atropine Sulfate Injection USP 0.6 mg/mL belongs to the pharmacotherapeutic group of anticholinergic agents (or antimuscarinics), specifically used for its spasmolytic, antisialagogue, and anti-vagal effects.
Indications
Atropine Sulfate Injection USP 0.6 mg/mL is an anticholinergic agent used primarily for emergency treatment of symptomatic bradycardia (slow heart rate), as a pre-anesthetic to reduce secretions, and as an antidote for organophosphate insecticide or nerve agent poisoning
Dosage Forms & Strength
Available Forms
Injection
Strength
0.6 mg/ml
Regulatory Approvals
WHO-GMP